Literature DB >> 8415640

ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias.

A R Moser1, E M Mattes, W F Dove, M J Lindstrom, J D Haag, M N Gould.   

Abstract

ApcMin (Min, multiple intestinal neoplasia) is a point mutation in the murine homolog of the APC gene. Min/+ mice develop multiple intestinal adenomas, as do humans carrying germ-line mutations in APC. Female mice carrying Min are also prone to develop mammary tumors. Min/+ mammary glands are more sensitive to chemical carcinogenesis than are +/+ mammary glands. Transplantation of mammary cells from Min/+ or +/+ donors into +/+ hosts demonstrates that the propensity to develop mammary tumors is intrinsic to the Min/+ mammary cells. Long-term grafts of Min/+ mammary glands also gave rise to focal alveolar hyperplasias, indicating that the presence of the Min mutation also has a role in the development of these lesions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415640      PMCID: PMC47484          DOI: 10.1073/pnas.90.19.8977

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Mammary tumorigenesis in 7,12-dimethybenzanthracene-treated C57BL x DBA/2f F1 mice.

Authors:  D Medina; J S Butel; S H Socher; F L Miller
Journal:  Cancer Res       Date:  1980-02       Impact factor: 12.701

2.  Familial polyposis.

Authors:  B M Boman; B Levin
Journal:  Hosp Pract (Off Ed)       Date:  1986-05-15

Review 3.  Retinoblastoma and the progression of tumor genetics.

Authors:  M F Hansen; W K Cavenee
Journal:  Trends Genet       Date:  1988-05       Impact factor: 11.639

4.  Induction of recessive lethal mutations in the T/t-H-2 region of the mouse genome by a point mutagen.

Authors:  A Shedlovsky; J L Guenet; L L Johnson; W F Dove
Journal:  Genet Res       Date:  1986-04       Impact factor: 1.588

5.  Mammary tumorigenesis in chemical carcinogen-treated mice. I. Incidence in BALB-c and C57BL mice.

Authors:  D Medina
Journal:  J Natl Cancer Inst       Date:  1974-07       Impact factor: 13.506

6.  A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.

Authors:  A R Moser; H C Pitot; W F Dove
Journal:  Science       Date:  1990-01-19       Impact factor: 47.728

7.  Influence of mouse major histocompatibility complex (H-2) on N-ethyl-N-nitrosourea-induced tumor formation in various organs.

Authors:  L C Oomen; M A van der Valk; A A Hart; P Demant; P Emmelot
Journal:  Cancer Res       Date:  1988-12-01       Impact factor: 12.701

8.  Supermutagenicity of ethylnitrosourea in the mouse spot test: comparisons with methylnitrosourea and ethylnitrosourethane.

Authors:  L B Russell; C S Montgomery
Journal:  Mutat Res       Date:  1982-02-22       Impact factor: 2.433

9.  Frequent somatic mutations of the APC gene in human pancreatic cancer.

Authors:  A Horii; S Nakatsuru; Y Miyoshi; S Ichii; H Nagase; H Ando; A Yanagisawa; E Tsuchiya; Y Kato; Y Nakamura
Journal:  Cancer Res       Date:  1992-12-01       Impact factor: 12.701

10.  Detection of ductal dysplasia in mammary outgrowths derived from carcinogen-treated virgin female BALB/c mice.

Authors:  S P Ethier; R L Ullrich
Journal:  Cancer Res       Date:  1982-05       Impact factor: 12.701

View more
  80 in total

1.  One hundred years of mouse genetics: an intellectual history. II. The molecular revolution (1981-2002).

Authors:  Kenneth Paigen
Journal:  Genetics       Date:  2003-04       Impact factor: 4.562

Review 2.  Wnt signaling in mammary glands: plastic cell fates and combinatorial signaling.

Authors:  Caroline M Alexander; Shruti Goel; Saja A Fakhraldeen; Soyoung Kim
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-10-01       Impact factor: 10.005

3.  Conjugated linoleic acids differentially alter polyp number and diameter in the Apc(min/+) mouse model of intestinal cancer.

Authors:  N Mandir; R A Goodlad
Journal:  Cell Prolif       Date:  2008-04       Impact factor: 6.831

4.  Detection of Premalignant Gastrointestinal Lesions Using Surface-Enhanced Resonance Raman Scattering-Nanoparticle Endoscopy.

Authors:  Stefan Harmsen; Stephan Rogalla; Ruimin Huang; Massimiliano Spaliviero; Volker Neuschmelting; Yoku Hayakawa; Yoomi Lee; Yagnesh Tailor; Ricardo Toledo-Crow; Jeon Woong Kang; Jason M Samii; Hazem Karabeber; Ryan M Davis; Julie R White; Matt van de Rijn; Sanjiv S Gambhir; Christopher H Contag; Timothy C Wang; Moritz F Kircher
Journal:  ACS Nano       Date:  2019-02-04       Impact factor: 15.881

Review 5.  The assessment of doses and effects from intakes of radioactive particles.

Authors:  J D Harrison; J W Stather
Journal:  J Anat       Date:  1996-12       Impact factor: 2.610

Review 6.  Harnessing preclinical mouse models to inform human clinical cancer trials.

Authors:  David H Gutmann; Kim Hunter-Schaedle; Kevin M Shannon
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

7.  Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein.

Authors:  S Munemitsu; I Albert; B Souza; B Rubinfeld; P Polakis
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 8.  Understanding phenotypic variation in rodent models with germline Apc mutations.

Authors:  Maged Zeineldin; Kristi L Neufeld
Journal:  Cancer Res       Date:  2013-04-11       Impact factor: 12.701

9.  Copy number abnormalities in sporadic canine colorectal cancers.

Authors:  Jie Tang; Shoshona Le; Liang Sun; Xiuzhen Yan; Mucheng Zhang; Jennifer Macleod; Bruce Leroy; Nicole Northrup; Angela Ellis; Timothy J Yeatman; Yanchun Liang; Michael E Zwick; Shaying Zhao
Journal:  Genome Res       Date:  2010-01-19       Impact factor: 9.043

Review 10.  Mouse models for studying angiogenesis and lymphangiogenesis in cancer.

Authors:  Lauri Eklund; Maija Bry; Kari Alitalo
Journal:  Mol Oncol       Date:  2013-03-05       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.